Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 30, 2023 |
Sep. 30, 2022 |
Sep. 30, 2023 |
Sep. 30, 2022 |
Dec. 31, 2022 |
Dec. 31, 2021 |
||||||||
| Income Statement [Abstract] | |||||||||||||
| REVENUES | $ 845 | $ 1,348 | $ 4,589 | $ 6,297 | $ 8,831 | $ 8,545 | |||||||
| COST OF REVENUES | 619 | 813 | 3,043 | 3,258 | 4,721 | 4,575 | |||||||
| GROSS PROFIT | 226 | 535 | 1,546 | 3,039 | 4,110 | 3,970 | |||||||
| OPERATING EXPENSES: | |||||||||||||
| Research and development expenses, net | 691 | 723 | 2,117 | 2,049 | 2,766 | 2,443 | |||||||
| Sales and marketing expenses, net | 691 | 790 | 2,332 | 2,357 | 3,282 | 2,204 | |||||||
| General and administrative expenses, net | 971 | 1,028 | 2,805 | 2,730 | 4,163 | 1,183 | |||||||
| TOTAL OPERATING EXPENSES | 2,353 | 2,541 | 7,254 | 7,136 | 10,211 | 5,830 | |||||||
| OPERATING LOSS | (2,127) | (2,006) | (5,708) | (4,097) | (6,101) | (1,860) | |||||||
| Interest expense | (161) | (198) | (512) | (622) | (830) | (690) | |||||||
| Other Financial income (expenses), net | 1,421 | (3) | 1,865 | (3,781) | (4,051) | (2,701) | |||||||
| NET COMPREHENSIVE LOSS FOR THE PERIOD | $ (867) | $ (2,207) | $ (4,355) | $ (8,500) | $ (10,982) | $ (5,251) | |||||||
| Net loss per share attributable to common shareholders – basic and diluted (in Dollars per share) | $ (0.32) | $ (1.27) | [1],[2] | $ (1.93) | [1],[2] | $ (8.77) | [1],[2] | $ (0.95) | $ (2.56) | ||||
| Weighted average number of common stocks used in computing net loss per share – basic and diluted (in Shares) | 2,685,626 | 1,731,753 | [2] | 2,254,235 | [2] | 968,721 | [2] | 11,621,238 | 2,048,788 | ||||
| |||||||||||||
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The costs incurred in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, excluding in-process research and development acquired in a business combination consummated during the period. Excludes software research and development, which has a separate concept. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|